WHO ICTRP trial
The effect of zinc and magnesium on postpartum depression and anxiety
IRCT2014100910324N19 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2014100910324N19 |
|---|---|
| Public title | The effect of zinc and magnesium on postpartum depression and anxiety |
| Scientific title | The effect of zinc and magnesium on postpartum depression and anxiety: a randomized controlled trial |
| Primary sponsor | Vice chancellor for research, Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | anxiety and depression. Mixed anxiety and depressive disorder;Mixed anxiety and depressive disorder |
| Interventions | Intervention 1: The first intervention group will receive Zinc sulfate tablet 27 mg oral, once a day for eight weeks. Intervention 2: The second intervention group will receive Magnesium sulfate tablet 320 mg oral, once a day for eight… |
| Registration date | Dec 26, 2014 |
| Target size | 99 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: